@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix entrez: . @prefix geneProductOf: . @prefix RNA: . @prefix hgnc: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: entrez:3630; a Protein: . sub:_2 geneProductOf: hgnc:8891; a RNA: . sub:_3 occursIn: obo:UBERON_0002107, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(EGID:3630) -> r(HGNC:PGD)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "To address the effects of LXR signaling in human livers, we have used genome-wide expression profiling of primary human hepatocytes cultured at varying physiological concentrations of insulin and treated them with the synthetic LXR agonist GW3965. 85 genes were significantly upregulated and 105 genes were significantly downregulated by insulin and GW3965 treatment, respectively. 38 genes were significantly upregulated and 84 genes were significantly downregulated by insulin alone. Fold change was 1.5 increase or decrease compared to control."; prov:wasQuotedFrom pubmed:17628011 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17628011; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:11.789+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }